Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George W Booz

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Journal of Cardiovascular Pharmacology|July 6, 2018
A Few Initial Thoughts on Receiving the BatonGeorge W Booz
Congestive Heart Failure (Greenwich, Conn.)|October 5, 2010
Deciphering STAT3 signaling in the heart: plasticity and vascular inflammationMazen Kurdi, George W Booz
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 3, 2007
Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cellsMazen Kurdi, George W Booz
Journal of Molecular and Cellular Cardiology|August 17, 2014
Carvedilol protects the infarcted heart by upregulating miR-133: first evidence that disease state affects β-adrenergic arrestin-biased signaling?Mazen Kurdi, George W Booz
Frontiers in Cardiovascular Medicine|September 26, 2019
Editorial: Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile FunctionRaffaele Altara, George W Booz
Journal of Cellular Physiology|March 28, 2007
Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROSMazen Kurdi, George W Booz
Journal of Cardiovascular Pharmacology|February 28, 2020
Deciphering the Dynamics and Therapeutic Potential of the Cardiac cGMP Cascade: An Update on Where We Are and What We Need to KnowRobert Lukowski, George W Booz
Clinical Science (London, England : 1979)|January 18, 2023
Central role for BRAF in cardiac hypertrophy: rethinking the pathological-physiological divideRaffaele Altara, George W Booz
Journal of Cardiovascular Pharmacology|September 10, 2019
Cardiovascular Pharmacology of the NLRP3 InflammasomeAntonio Abbate, George W Booz
Journal of Cardiovascular Pharmacology|August 19, 2007
Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signalingMazen Kurdi, George W Booz
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Journal of Cardiovascular Pharmacology|July 6, 2018
A Few Initial Thoughts on Receiving the BatonGeorge W Booz
Congestive Heart Failure (Greenwich, Conn.)|October 5, 2010
Deciphering STAT3 signaling in the heart: plasticity and vascular inflammationMazen Kurdi, George W Booz
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 3, 2007
Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cellsMazen Kurdi, George W Booz
Journal of Molecular and Cellular Cardiology|August 17, 2014
Carvedilol protects the infarcted heart by upregulating miR-133: first evidence that disease state affects β-adrenergic arrestin-biased signaling?Mazen Kurdi, George W Booz
Frontiers in Cardiovascular Medicine|September 26, 2019
Editorial: Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile FunctionRaffaele Altara, George W Booz
Journal of Cellular Physiology|March 28, 2007
Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROSMazen Kurdi, George W Booz
Journal of Cardiovascular Pharmacology|February 28, 2020
Deciphering the Dynamics and Therapeutic Potential of the Cardiac cGMP Cascade: An Update on Where We Are and What We Need to KnowRobert Lukowski, George W Booz
Clinical Science (London, England : 1979)|January 18, 2023
Central role for BRAF in cardiac hypertrophy: rethinking the pathological-physiological divideRaffaele Altara, George W Booz
Journal of Cardiovascular Pharmacology|September 10, 2019
Cardiovascular Pharmacology of the NLRP3 InflammasomeAntonio Abbate, George W Booz
Journal of Cardiovascular Pharmacology|August 19, 2007
Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signalingMazen Kurdi, George W Booz
Pageof 19